4-100421321-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016242.4(EMCN):āc.625C>Gā(p.Leu209Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,612,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016242.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EMCN | NM_016242.4 | c.625C>G | p.Leu209Val | missense_variant | 8/12 | ENST00000296420.9 | |
EMCN | NM_001159694.2 | c.586C>G | p.Leu196Val | missense_variant | 7/11 | ||
EMCN | XM_011532024.4 | c.625C>G | p.Leu209Val | missense_variant | 8/12 | ||
LOC124900740 | XR_007058203.1 | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EMCN | ENST00000296420.9 | c.625C>G | p.Leu209Val | missense_variant | 8/12 | 1 | NM_016242.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151948Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 250938Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135622
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1460700Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 726654
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151948Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74214
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.625C>G (p.L209V) alteration is located in exon 8 (coding exon 8) of the EMCN gene. This alteration results from a C to G substitution at nucleotide position 625, causing the leucine (L) at amino acid position 209 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at